{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:42:50Z","timestamp":1794476570284,"version":"4.9.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11864-020-00802-3","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T17:05:25Z","timestamp":1606151125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Progress on Management of Penile Cancer in 2020"],"prefix":"10.1007","volume":"22","author":[{"given":"Mohamed E.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud I.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"issue":"1","key":"802_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"\u2022 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330 Herein, the American cancer society estimates the number of new cancer cases as well as cancer deaths for 2020.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"802_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.currproblcancer.2015.03.010","volume":"39","author":"M Christodoulidou","year":"2015","unstructured":"Christodoulidou M, Sahdev V, Houssein S, Muneer A. Epidemiology of penile cancer. Curr Probl Cancer. 2015;39(3):126\u201336.","journal-title":"Curr Probl Cancer"},{"issue":"1","key":"802_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93\u2013105.","journal-title":"Eur Urol"},{"issue":"2","key":"802_CR4","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"\u2022\u2022 Amin MB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA: a cancer journal for clinicians. 2017;67(2):93\u20139 The eighth edition of AJCC cancer staging; including the updated TNM staging system for penile cancer.","journal-title":"CA: a cancer journal for clinicians"},{"issue":"5","key":"802_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1464-410X.1994.tb09200.x","volume":"74","author":"S Opjordsmoen","year":"1994","unstructured":"Opjordsmoen S, Foss\u00e5 SD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol. 1994;74(5):652\u20137.","journal-title":"Br J Urol"},{"issue":"2","key":"802_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00345-008-0312-x","volume":"27","author":"PK Hegarty","year":"2009","unstructured":"Hegarty PK, Shabbir M, Hughes B, Minhas S, Perry M, Watkin N, et al. Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience. World J Urol. 2009;27(2):179\u201387.","journal-title":"World J Urol"},{"issue":"3","key":"802_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/CCO.0b013e3283376ac0","volume":"22","author":"JR Rossari","year":"2010","unstructured":"Rossari JR, Vora T, Gil T. Advances in penile cancer management. Curr Opin Oncol. 2010;22(3):226\u201335.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"802_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.eururo.2007.10.028","volume":"54","author":"E Skeppner","year":"2008","unstructured":"Skeppner E, Windahl T, Andersson SO, Fugl-Meyer KS. Treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma. Eur Urol. 2008;54(3):631\u20139.","journal-title":"Eur Urol"},{"issue":"5","key":"802_CR9","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.juro.2007.07.039","volume":"178","author":"AW Shindel","year":"2007","unstructured":"Shindel AW, Mann MW, Lev RY, Sengelmann R, Petersen J, Hruza GJ, et al. Mohs micrographic surgery for penile cancer: management and long-term followup. J Urol. 2007;178(5):1980\u20135.","journal-title":"J Urol"},{"issue":"6","key":"802_CR10","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1097\/01.ju.0000067361.81295.a2","volume":"169","author":"T Windahl","year":"2003","unstructured":"Windahl T, Andersson S-O. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol. 2003;169(6):2118\u201321.","journal-title":"J Urol"},{"issue":"2","key":"802_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2006.03.063","volume":"176","author":"A Lont","year":"2006","unstructured":"Lont A, et al. Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol. 2006;176(2):575\u201380.","journal-title":"J Urol"},{"issue":"2","key":"802_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","volume":"27","author":"MC Bleeker","year":"2009","unstructured":"Bleeker MC, et al. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27(2):141\u201350.","journal-title":"World J Urol"},{"key":"802_CR13","doi-asserted-by":"crossref","unstructured":"Favorito LA, Nardi AC, Ronalsa M, Zequi SC, Sampaio FJB, Glina S. Epidemiologic study on penile cancer in Brazil. Int Braz J Urol. 2008;34(5):587\u201391 discussion 591-3.","DOI":"10.1590\/S1677-55382008000500007"},{"issue":"S10","key":"802_CR14","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1002\/cncr.23743","volume":"113","author":"BY Hernandez","year":"2008","unstructured":"Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003. Cancer. 2008;113(S10):2883\u201391.","journal-title":"Cancer"},{"issue":"10","key":"802_CR15","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1158\/1055-9965.EPI-08-0456","volume":"17","author":"BS Madsen","year":"2008","unstructured":"Madsen BS, van den Brule AJC, Jensen HL, Wohlfahrt J, Frisch M. Risk factors for squamous cell carcinoma of the penis\u2014population-based case-control study in Denmark. Cancer Epidemiol Prev Biomarkers. 2008;17(10):2683\u201391.","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"issue":"1","key":"802_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","volume":"85","author":"C Maden","year":"1993","unstructured":"Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. JNCI: J Natl Cancer Inst. 1993;85(1):19\u201324.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"5","key":"802_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.mayocp.2014.01.001","volume":"89","author":"BJ Morris","year":"2014","unstructured":"Morris BJ, Bailis SA, Wiswell TE. Circumcision rates in the United States: rising or falling? What effect might the new affirmative pediatric policy statement have? Mayo Clin Proc. 2014;89(5):677\u201386.","journal-title":"Mayo Clin Proc"},{"key":"802_CR18","doi-asserted-by":"publisher","first-page":"812368","DOI":"10.1155\/2011\/812368","volume":"2011","author":"BJ Morris","year":"2011","unstructured":"Morris BJ, et al. The strong protective effect of circumcision against cancer of the penis. Adv Urol. 2011;2011:812368.","journal-title":"Adv Urol"},{"issue":"1","key":"802_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5409\/wjcp.v6.i1.89","volume":"6","author":"BJ Morris","year":"2017","unstructured":"\u2022\u2022 Morris BJ, et al. Early infant male circumcision: systematic review, risk-benefit analysis, and progress in policy. World J Clin Pediatr. 2017;6(1):89\u2013102 Systematic review on the risk and benefits of early infant male circumcission.","journal-title":"World J Clin Pediatr"},{"key":"802_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/ijpvm.IJPVM_377_16","volume":"8","author":"BJ Morris","year":"2017","unstructured":"\u2022 Morris BJ, Krieger JN. Penile inflammatory skin disorders and the preventive role of circumcision. Int J Prev Med. 2017;8:32 This is a recent review article on the preventive role of circumcision on the inflammatory skin diseases of the penis.","journal-title":"Int J Prev Med"},{"key":"802_CR21","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics Task Force on Circumcision. Circumcision policy statement. Pediatrics. 2012;130(3):585\u20136.","DOI":"10.1542\/peds.2012-1989"},{"issue":"11","key":"802_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020298","volume":"2","author":"B Auvert","year":"2005","unstructured":"Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298.","journal-title":"PLoS Med"},{"issue":"9562","key":"802_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","volume":"369","author":"RC Bailey","year":"2007","unstructured":"Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643\u201356.","journal-title":"Lancet"},{"key":"802_CR24","volume-title":"WHO\/UNAIDS technical consultation on male circumcision and HIV prevention: research implications for policy and programming\u2013conclusions and recommendations (6\u20138 March 2007)","author":"U WHO","year":"2007","unstructured":"WHO U. WHO\/UNAIDS technical consultation on male circumcision and HIV prevention: research implications for policy and programming\u2013conclusions and recommendations (6\u20138 March 2007). Montreux: World Health Organization and Joint United Nations Programme on HIV. AIDS; 2007."},{"issue":"11","key":"802_CR25","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/jsm.12293","volume":"10","author":"BJ Morris","year":"2013","unstructured":"Morris BJ, Krieger JN. Does male circumcision affect sexual function, sensitivity, or satisfaction?--a systematic review. J Sex Med. 2013;10(11):2644\u201357.","journal-title":"J Sex Med"},{"key":"802_CR26","volume-title":"Cancer incidence in five continents","author":"DM Parkin","year":"1997","unstructured":"Parkin DM. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer World Health Organization; 1997."},{"issue":"9","key":"802_CR27","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/ijc.27650","volume":"131","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, de Sanjos\u00e9 S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer. 2012;131(9):1969\u201382.","journal-title":"Int J Cancer"},{"issue":"5","key":"802_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.21037\/tau.2017.06.27","volume":"6","author":"LC Kidd","year":"2017","unstructured":"\u2022 Kidd LC, et al. Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. Transl Androl Urol. 2017;6(5):791\u2013802 This is a recent review on the HPV pathogenesis\/carcinogenesis, and its current and future treatment options.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"802_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","volume":"16","author":"T Harder","year":"2018","unstructured":"\u2022\u2022 Harder T, et al. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. 2018;16(1):110 Systematic review on the efficacy, effectivness and safety of Human papillomavirus vaccination in males.","journal-title":"BMC Med"},{"issue":"3","key":"802_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1523-1747.2000.00069.x","volume":"115","author":"U Wieland","year":"2000","unstructured":"Wieland U, Jurk S, Wei\u00dfenborn S, Pfister H, Krieg T, Ritzkowsky A. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol. 2000;115(3):396\u2013401.","journal-title":"J Invest Dermatol"},{"issue":"2 Suppl 1","key":"802_CR31","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.urology.2010.04.007","volume":"76","author":"S Minhas","year":"2010","unstructured":"Minhas S, Manseck A, Watya S, Hegarty PK. Penile cancer--prevention and premalignant conditions. Urology. 2010;76(2 Suppl 1):S24\u201335.","journal-title":"Urology"},{"issue":"3","key":"802_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/1756287211412657","volume":"3","author":"M Shabbir","year":"2011","unstructured":"Shabbir M, Minhas S, Muneer A. Diagnosis and management of premalignant penile lesions. Ther Adv Urol. 2011;3(3):151\u20138.","journal-title":"Ther Adv Urol"},{"issue":"12","key":"802_CR33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1524-4725.1980.tb01026.x","volume":"6","author":"GR Mikhail","year":"1980","unstructured":"Mikhail GR. Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol. 1980;6(12):1027\u201335.","journal-title":"J Dermatol Surg Oncol"},{"issue":"3","key":"802_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/archderm.136.3.350","volume":"136","author":"E Mallon","year":"2000","unstructured":"Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, et al. Circumcision and genital dermatoses. Arch Dermatol. 2000;136(3):350\u20134.","journal-title":"Arch Dermatol"},{"key":"802_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2431-12-20","volume":"12","author":"BJ Morris","year":"2012","unstructured":"Morris BJ, Waskett JH, Banerjee J, Wamai RG, Tobian AAR, Gray RH, et al. A \u2018snip\u2019 in time: what is the best age to circumcise? BMC Pediatr. 2012;12:20.","journal-title":"BMC Pediatr"},{"key":"802_CR36","first-page":"65","volume":"138","author":"F Faggiano","year":"1997","unstructured":"Faggiano F, et al. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ. 1997;138:65\u2013176.","journal-title":"IARC Sci Publ"},{"issue":"2","key":"802_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bju.13534","volume":"119","author":"C Torbrand","year":"2017","unstructured":"\u2022 Torbrand C, et al. Socioeconomic factors and penile cancer risk and mortality; a population-based study. BJU Int. 2017;119(2):254\u201360 This is a population-based study discussing the association between socioeconomic status and penile cancer.","journal-title":"BJU Int"},{"issue":"5","key":"802_CR38","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ijc.28107","volume":"133","author":"CJ Ulff-M\u00f8ller","year":"2013","unstructured":"Ulff-M\u00f8ller CJ, Simonsen J, Frisch M. Marriage, cohabitation and incidence trends of invasive penile squamous cell carcinoma in Denmark 1978-2010. Int J Cancer. 2013;133(5):1173\u20139.","journal-title":"Int J Cancer"},{"issue":"1","key":"802_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12894-016-0161-7","volume":"16","author":"KT Barnes","year":"2016","unstructured":"Barnes KT, McDowell BD, Button A, Smith BJ, Lynch CF, Gupta A. Obesity is associated with increased risk of invasive penile cancer. BMC Urol. 2016;16(1):42.","journal-title":"BMC Urol"},{"issue":"3","key":"802_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/A:1011266405062","volume":"12","author":"HF Tsen","year":"2001","unstructured":"Tsen HF, et al. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001;12(3):267\u201377.","journal-title":"Cancer Causes Control"},{"issue":"Suppl 3","key":"802_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","volume":"26","author":"E Archier","year":"2012","unstructured":"Archier E, Devaux S, Castela E, Gallini A, Aubin F, le Ma\u00eetre M, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):22\u201331.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"802_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.semdp.2011.08.009","volume":"29","author":"EF Velazquez","year":"2012","unstructured":"Velazquez EF, Chaux A, Cubilla AL. Histologic classification of penile intraepithelial neoplasia. Semin Diagn Pathol. 2012;29(2):96\u2013102.","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"802_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.semdp.2014.12.018","volume":"32","author":"DF Sanchez","year":"2015","unstructured":"Sanchez DF, Ca\u00f1ete S, Fern\u00e1ndez-Nestosa MJ, Lezcano C, Rodr\u00edguez I, Barreto J, et al. HPV- and non-HPV-related subtypes of penile squamous cell carcinoma (SCC): morphological features and differential diagnosis according to the new WHO classification (2015). Semin Diagn Pathol. 2015;32(3):198\u2013221.","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"802_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/bju.13041","volume":"117","author":"V Hanchanale","year":"2016","unstructured":"Hanchanale V, Yeo L, Subedi N, Smith J, Wah T, Harnden P, et al. The accuracy of magnetic resonance imaging (MRI) in predicting the invasion of the tunica albuginea and the urethra during the primary staging of penile cancer. BJU Int. 2016;117(3):439\u201343.","journal-title":"BJU Int"},{"issue":"2","key":"802_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jso.20414","volume":"93","author":"D Pandey","year":"2006","unstructured":"Pandey D, Mahajan V, Kannan RR. Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol. 2006;93(2):133\u20138.","journal-title":"J Surg Oncol"},{"issue":"2 Suppl 1","key":"802_CR46","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","volume":"76","author":"V Ficarra","year":"2010","unstructured":"Ficarra V, Akduman B, Bouchot O, Palou J, Tobias-Machado M. Prognostic factors in penile cancer. Urology. 2010;76(2 Suppl 1):S66\u201373.","journal-title":"Urology"},{"key":"802_CR47","doi-asserted-by":"crossref","unstructured":"Johnston MJ, Nigam R. Recent advances in the management of penile cancer. F1000Res. 2019;8 This a very recent review covering advances in the management of penile cancer. https:\/\/f1000research.com\/articles\/8-558. Accessed Sept 2020.","DOI":"10.12688\/f1000research.18185.1"},{"issue":"5","key":"802_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","volume":"37","author":"R Sadeghi","year":"2012","unstructured":"Sadeghi R, Gholami H, Zakavi SR, Kakhki VRD, Horenblas S. Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med. 2012;37(5):436\u201341.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"802_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.eururo.2007.01.107","volume":"52","author":"JA Leijte","year":"2007","unstructured":"Leijte JA, et al. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol. 2007;52(1):170\u20137.","journal-title":"Eur Urol"},{"issue":"2","key":"802_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/bju.13009","volume":"116","author":"JM Gopman","year":"2015","unstructured":"Gopman JM, Djajadiningrat RS, Baumgarten AS, Espiritu PN, Horenblas S, Zhu Y, et al. Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort. BJU Int. 2015;116(2):196\u2013201.","journal-title":"BJU Int"},{"issue":"7","key":"802_CR51","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s00259-017-3636-1","volume":"44","author":"ZZ Saad","year":"2017","unstructured":"\u2022\u2022 Saad ZZ, et al. Investigating the role of SPECT\/CT in dynamic sentinel lymph node biopsy for penile cancers. Eur J Nucl Med Mol Imaging. 2017;44(7):1176\u201384 This is a prospective study investigating the use of SPECT\/CT in patients undergoing pre-operative imaging prior to sentinel lymph node biopsy.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"802_CR52","doi-asserted-by":"crossref","unstructured":"Faut M, et al. Morbidity after inguinal lymph node dissections: it is time for a change. Ann Surg Oncol. 2017;24(2):330\u20139 This retrospective study investigated the impact of preoperative care protocols on the postoperative complications after inguinal lymph node dissection.","DOI":"10.1245\/s10434-016-5461-3"},{"issue":"5","key":"802_CR53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.eururo.2012.02.052","volume":"62","author":"HM Alnajjar","year":"2012","unstructured":"Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJA, Watkin NA. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol. 2012;62(5):923\u20138.","journal-title":"Eur Urol"},{"issue":"4","key":"802_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1067\/mjd.2002.120444","volume":"46","author":"TL Schroeder","year":"2002","unstructured":"Schroeder TL, Sengelmann RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol. 2002;46(4):545\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"802_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00345-008-0309-5","volume":"27","author":"J Crook","year":"2009","unstructured":"Crook J, Ma C, Grimard L. Radiation therapy in the management of the primary penile tumor: an update. World J Urol. 2009;27(2):189\u201396.","journal-title":"World J Urol"},{"issue":"6","key":"802_CR56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1464-410X.2009.09188.x","volume":"106","author":"B Schlenker","year":"2010","unstructured":"Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, et al. Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 2010;106(6):786\u201390.","journal-title":"BJU Int"},{"issue":"7","key":"802_CR57","first-page":"878","volume":"34","author":"JP Hansen","year":"2008","unstructured":"Hansen JP, Drake AL, Walling HW. Bowen\u2019s disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg. 2008;34(7):878\u201383.","journal-title":"Dermatol Surg"},{"issue":"3","key":"802_CR58","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ucl.2010.04.004","volume":"37","author":"J Crook","year":"2010","unstructured":"Crook J. Radiation therapy for cancer of the penis. Urol Clin. 2010;37(3):435\u201343.","journal-title":"Urol Clin"},{"issue":"6","key":"802_CR59","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/bju.12338","volume":"114","author":"PK Hegarty","year":"2014","unstructured":"Hegarty PK, Eardley I, Heidenreich A, McDougal WS, Minhas S, Spiess PE, et al. Penile cancer: organ-sparing techniques. BJU Int. 2014;114(6):799\u2013805.","journal-title":"BJU Int"},{"key":"802_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2008\/634216","volume":"2008","author":"FE Martins","year":"2008","unstructured":"Martins FE, Rodrigues RN, Lopes TM. Organ-preserving surgery for penile carcinoma. Advances in urology. 2008;2008:1\u20137.","journal-title":"Advances in urology"},{"issue":"5","key":"802_CR61","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.urology.2011.08.006","volume":"78","author":"J Li","year":"2011","unstructured":"Li J, Zhu Y, Zhang SL, Wang CF, Yao XD, Dai B, et al. Organ-sparing surgery for penile cancer: complications and outcomes. Urology. 2011;78(5):1121\u20134.","journal-title":"Urology"},{"issue":"2","key":"802_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.eururo.2016.09.048","volume":"73","author":"AS Parnham","year":"2018","unstructured":"\u2022 Parnham AS, et al. Glansectomy and split-thickness skin graft for penile cancer. Eur Urol. 2018;73(2):284\u20139 This is a recent retrospective study of the safety and effectiveness of Glansectomy and Split-thickness Skin graft in penile reconstruction.","journal-title":"Eur Urol"},{"issue":"Suppl 2","key":"802_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/bju.12205","volume":"112","author":"M Zukiwskyj","year":"2013","unstructured":"Zukiwskyj M, Daly P, Chung E. Penile cancer and phallus preservation strategies: a review of current literature. BJU Int. 2013;112(Suppl 2):21\u20136.","journal-title":"BJU Int"},{"issue":"3","key":"802_CR64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","volume":"188","author":"P Philippou","year":"2012","unstructured":"Philippou P, Shabbir M, Malone P, Nigam R, Muneer A, Ralph DJ, et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol. 2012;188(3):803\u20138.","journal-title":"J Urol"},{"issue":"7","key":"802_CR65","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1464-410X.2005.05769.x","volume":"96","author":"S Minhas","year":"2005","unstructured":"Minhas S, Kayes O, Hegarty P, Kumar P, Freeman A, Ralph D. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96(7):1040\u20133.","journal-title":"BJU Int"},{"issue":"1","key":"802_CR66","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.juro.2010.09.010","volume":"185","author":"JJ Belinky","year":"2011","unstructured":"Belinky JJ, Cheliz GM, Graziano CA, Rey HM. Glanuloplasty with urethral flap after partial penectomy. J Urol. 2011;185(1):204\u20136.","journal-title":"J Urol"},{"issue":"6","key":"802_CR67","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1464-410X.2009.08424.x","volume":"104","author":"G Garaffa","year":"2009","unstructured":"Garaffa G, Raheem AA, Christopher NA, Ralph DJ. Total phallic reconstruction after penile amputation for carcinoma. BJU Int. 2009;104(6):852\u20136.","journal-title":"BJU Int"},{"issue":"1","key":"802_CR68","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","volume":"54","author":"JA Leijte","year":"2008","unstructured":"Leijte JA, et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161\u20138.","journal-title":"Eur Urol"},{"key":"802_CR69","volume-title":"Urologic Oncology: Seminars and Original Investigations","author":"Z-S Li","year":"2014","unstructured":"Li Z-S, et al. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density. In: Urologic Oncology: Seminars and Original Investigations. Amsterdam: Elsevier; 2014."},{"issue":"10","key":"802_CR70","doi-asserted-by":"publisher","first-page":"471.e19-471.e27","DOI":"10.1016\/j.urolonc.2018.07.010","volume":"36","author":"N Soodana-Prakash","year":"2018","unstructured":"\u2022 Soodana-Prakash N, et al. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer. Urol Oncol. 2018;36(10):471.e19-471.e27 This is a recent national cancer data base study on the prognostic value of number of lymph nodes after ILD on the overall survival.","journal-title":"Urol Oncol"},{"issue":"2","key":"802_CR71","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.juro.2010.03.140","volume":"184","author":"K Yao","year":"2010","unstructured":"Yao K, Tu H, Li YH, Qin ZK, Liu ZW, Zhou FJ, et al. Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol. 2010;184(2):546\u201352.","journal-title":"J Urol"},{"issue":"6","key":"802_CR72","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.juro.2013.06.016","volume":"190","author":"L Koifman","year":"2013","unstructured":"Koifman L, Hampl D, Koifman N, Vides AJ, Ornellas AA. Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes. J Urol. 2013;190(6):2086\u201392.","journal-title":"J Urol"},{"issue":"1","key":"802_CR73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-7819-11-42","volume":"11","author":"HS Pahwa","year":"2013","unstructured":"Pahwa HS, Misra S, Kumar A, Kumar V, Agarwal A, Srivastava R. Video Endoscopic Inguinal Lymphadenectomy (VEIL)-a prospective critical perioperative assessment of feasibility and morbidity with points of technique in penile carcinoma. World journal of surgical oncology. 2013;11(1):42.","journal-title":"World journal of surgical oncology"},{"key":"802_CR74","unstructured":"O.W. Hakenberg, E. Comp\u00e9rat, S. Minhas, A. Necchi, C. Protzel, N. Watkin The European Association of Urology (EAU) guidelines on penile cancer. 2018; Available from: https:\/\/uroweb.org\/guideline\/penile-cancer\/. This is the summary of the recent EAU guideline on the management of penile cancer."},{"issue":"1","key":"802_CR75","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg OW, Comp\u00e9rat EM, Minhas S, Necchi A, Protzel C, Watkin N. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2015;67(1):142\u201350.","journal-title":"Eur Urol"},{"issue":"4","key":"802_CR76","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","volume":"177","author":"C Bermejo","year":"2007","unstructured":"Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol. 2007;177(4):1335\u20138.","journal-title":"J Urol"},{"issue":"Suppl 1","key":"802_CR77","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.21037\/tau.2019.01.05","volume":"8","author":"HM Alnajjar","year":"2019","unstructured":"\u2022 Alnajjar HM, et al. Long-term outcomes for penile cancer patients presenting with advanced N3 disease requiring a myocutaneous flap reconstruction or primary closure\u2014a retrospective single centre study. Transl Androl Urol. 2019;8(Suppl 1):S13 This is a retrospective study comparing the outcomes of myocutaneous flap reconstruction versus primary closure in patients with N3 advanced metastatic penile cancer.","journal-title":"Transl Androl Urol"},{"issue":"24","key":"802_CR78","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol. 2010;28(24):3851\u20137.","journal-title":"J Clin Oncol"},{"issue":"5","key":"802_CR79","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","volume":"5","author":"DJ Canter","year":"2019","unstructured":"\u2022 Canter DJ, et al. The International Penile Advanced Cancer Trial (InPACT): rationale and current status. Eur Urol Focus. 2019;5(5):706\u20139 This is an overview of the international penile advanced Cancer trial (InPACT) design. This is an international prospective study of treatment sequencing and adjuvant therapies in patients with locally advanced penile cancer.","journal-title":"Eur Urol Focus"},{"issue":"10","key":"802_CR80","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1038\/bjc.2013.620","volume":"109","author":"S Nicholson","year":"2013","unstructured":"Nicholson S, Hall E, Harland SJ, Chester JD, Pickering L, Barber J, et al. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001). Br J Cancer. 2013;109(10):2554\u20139.","journal-title":"Br J Cancer"},{"issue":"4","key":"802_CR81","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","volume":"14","author":"N Nicolai","year":"2016","unstructured":"Nicolai N, Sangalli LM, Necchi A, Giannatempo P, Paganoni AM, Colecchia M, et al. A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings. Clin Genitourin Cancer. 2016;14(4):323\u201330.","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"802_CR82","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bju.14013","volume":"121","author":"A Necchi","year":"2018","unstructured":"\u2022\u2022 Necchi A, et al. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study. BJU Int. 2018;121(3):348\u201356 Recent phase 2 clinical trial on using pan-HER tyrosine kinase in locally advanced and metatsatic penile cancer.","journal-title":"BJU Int"},{"key":"802_CR83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.humpath.2016.09.003","volume":"59","author":"M Cocks","year":"2017","unstructured":"\u2022\u2022 Cocks M, et al. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort. Hum Pathol. 2017;59:55\u201361 The largest study in north america to study PD-L1 expression in penile squamous cell carcinoma.","journal-title":"Hum Pathol"},{"issue":"3","key":"802_CR84","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/j.clgc.2019.10.014","volume":"18","author":"MW De Bacco","year":"2020","unstructured":"\u2022\u2022 De Bacco MW, et al. PD-L1 and p16 expression in penile squamous cell carcinoma from an endemic region. Clin Genitourin Cancer. 2020;18(3):e254\u20139 This is a recent study investigating the association between PD-L1 and p16 expression and oncologic outcomes in penile squamous cell carcinoma.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"802_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","volume":"74","author":"R Robinson","year":"2018","unstructured":"\u2022\u2022 Robinson R, et al. Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node-positive penile cancer: a systematic review by the European Association of Urology Penile Cancer guidelines panel. Eur Urol. 2018;74(1):76\u201383 Recent Systematic review on the outcomes of adjuvant radiation therapy following inguinal lymphnode dissection in lymph node positive penile cancer patients.","journal-title":"Eur Urol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-00802-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-020-00802-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-00802-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T19:45:10Z","timestamp":1610221510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-020-00802-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1007\/s11864-020-00802-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"11 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mohamed E. Ahmed declares that he has no conflict of interest. Mahmoud I. Khalil declares that he has no conflict of interest. Mohamed H. Kamel declares that he has no conflict of interest. R. Jeffrey Karnes declares that he has no conflict of interest. Philippe E. Spiess is Vice Chair, National Comprehensive Cancer Network (NCCN) Penile and Bladder Cancer Panel.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"4"}}